DSFRX
Price
$37.87
Change
+$0.42 (+1.12%)
Updated
Jan 17 closing price
Net Assets
1.15B
RGEBX
Price
$73.84
Change
+$0.83 (+1.14%)
Updated
Jan 17 closing price
Net Assets
303.09B
Ad is loading...

DSFRX vs RGEBX

Header iconDSFRX vs RGEBX Comparison
Open Charts DSFRX vs RGEBXBanner chart's image
Domini Impact Equity Y
Price$37.87
Change+$0.42 (+1.12%)
VolumeN/A
Net Assets1.15B
American Funds Growth Fund of Amer R2E
Price$73.84
Change+$0.83 (+1.14%)
VolumeN/A
Net Assets303.09B
DSFRX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DSFRX vs. RGEBX commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSFRX is a Hold and RGEBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 303B vs. DSFRX (1.15B). DSFRX pays higher dividends than RGEBX: DSFRX (0.69) vs RGEBX (0.16). DSFRX was incepted earlier than RGEBX: DSFRX (21 years) vs RGEBX (10 years). RGEBX is a more actively managed with annual turnover of: 31.00 vs. DSFRX (9.00). DSFRX has a lower initial minimum investment than RGEBX: DSFRX (0) vs RGEBX (250). RGEBX annual gain was more profitable for investors over the last year : 21.39 vs. DSFRX (17.83). DSFRX return over 5 years is better than : 57.25 vs. RGEBX (42.23).
DSFRXRGEBXDSFRX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years10 years-
Gain YTD1.6923.35950%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.15B303B0%
Annual Yield % from dividends0.690.16437%
Returns for 1 year17.8321.3983%
Returns for 3 years18.4410.90169%
Returns for 5 years57.2542.23136%
Returns for 10 years-17.3876.54-23%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONCO0.530.02
+3.37%
Onconetix Inc
RERE2.640.05
+1.93%
ATRenew
AEG6.370.06
+0.95%
Aegon Ltd
JANX40.720.11
+0.27%
Janux Therapeutics
EBS9.88-0.09
-0.90%
Emergent Biosolutions